Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$24.35 - $44.39 $226,455 - $412,827
-9,300 Reduced 18.56%
40,800 $993,000
Q1 2024

May 14, 2024

BUY
$31.23 - $42.99 $1.56 Million - $2.15 Million
50,100 New
50,100 $1.69 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.